Anupam Rasayan India Ltd., a custom synthesis and specialty chemicals company, announced its consolidated financial results for the quarter ended December 31, 2025. The company delivered solid year-on-year growth, driven by robust demand and strategic expansion initiatives.
Q3 FY26 Consolidated Financial Highlights
Anupam Rasayan reported total revenue of ₹5,145 million in Q3 FY26, compared to ₹3,866 million in Q3 FY25. This marks an impressive 33% year-on-year growth, reflecting strong execution across key business segments.
EBITDA Maintains Healthy Margin
EBITDA (including other income) stood at ₹1,296 million in Q3 FY26, up 7% from ₹1,208 million in the corresponding quarter last year. Despite input cost dynamics, the company maintained a healthy EBITDA margin of 25.20%, underlining operational efficiency and cost discipline.
Profit After Tax Grows 12%
Profit After Tax (PAT) increased to ₹606 million, compared to ₹542 million in Q3 FY25, registering a 12% YoY growth. The improvement in profitability highlights steady margin performance and business momentum.
Nine-Month FY26 Performance Highlights
For the nine months ended December 31, 2025, Anupam Rasayan achieved consolidated revenue of ₹17,297 million. During the same period, EBITDA reached ₹4,024 million, reflecting sustained year-on-year growth and consistent operational performance.
Strategic Expansion: Acquisition of Jayhawk Fine Chemicals
In a significant strategic move, Anupam Rasayan signed a definitive agreement to acquire Jayhawk Fine Chemicals Corporation (USA). This acquisition marks a key milestone in the company’s global growth strategy.
By acquiring Jayhawk, Anupam Rasayan will:
*Strengthen its presence in the United States
*Enhance advanced custom synthesis capabilities
*Expand access to regulated markets
*Deepen relationships with innovator customers in North America
This development positions the company to accelerate its transformation into a global specialty chemical platform.
Management Commentary
Anand Desai, Managing Director, said, “I am pleased to share that for the nine months of FY26, we delivered consolidated revenue of ₹17,297 million with EBITDA of ₹4,024 million, reflecting strong year-on-year growth. For Q3 FY26, revenue stood at ₹5,124 million with EBITDA of ₹1,296 million, demonstrating continued growth momentum. A significant strategic development during the period has been the signing of a definitive agreement to acquire Jayhawk Fine Chemicals Corporation in the United States. This acquisition strengthens our global footprint, enhances our capabilities in advanced custom synthesis, and deepens our access to regulated markets and innovator customers in North America. It represents an important step in our journey toward becoming a global specialty chemical platform.”
Outlook
As per the press release, with steady financial growth and a strategic international acquisition underway, Anupam Rasayan continues to reinforce its position as a leading player in the global specialty chemicals and custom synthesis industry.
